Bromo-Thiazole

Bromo-Thiazole


    • Product Name Bromo-Thiazole
    • Alias BromoThiazole
    • Einecs 813-226-8
    • Mininmum Order 1 g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    333134

    Name Bromo - Thiazole
    Chemical Formula C3H2BrNS
    Molar Mass 162.02 g/mol
    Appearance Typically a solid or liquid (depending on substitution and conditions)
    Odor May have a characteristic, often pungent odor
    Solubility In Water Poorly soluble in water
    Solubility In Organic Solvents Soluble in common organic solvents like ethanol, dichloromethane
    Melting Point Varies based on specific isomer and substitution
    Boiling Point Varies based on specific isomer and substitution
    Density Varies based on specific isomer and conditions
    Reactivity Reactive towards nucleophiles due to the presence of bromine and the heterocyclic ring

    As an accredited Bromo-Thiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Bromo - Thiazole packaged in a sealed, corrosion - resistant container.
    Shipping Bromo - Thiazole is shipped in sealed, corrosion - resistant containers. Adequate cushioning is used to prevent breakage. Shipments follow strict hazardous chemical regulations, ensuring safe transport by land or sea.
    Storage Bromo - Thiazole should be stored in a cool, dry, well - ventilated area, away from heat sources and ignition points. It should be kept in a tightly - sealed container to prevent leakage and exposure to air or moisture, which could potentially cause decomposition or reaction. Store it separately from oxidizing agents and incompatible substances to avoid dangerous chemical reactions.
    Application of Bromo-Thiazole

    Halogen Exchange Reactivity Gradients in Thiamethoxam Precursor Synthesis

    For the industrial manufacture of thiamethoxam (FAO Specification 717/2008), 2-bromo-5-methylthiazole serves as the foundational C-5 heterocycle. The critical pathway is a copper(I)-catalyzed halogen exchange to yield 2-chloro-5-methylthiazole, subsequently chlorinated at the methyl position with sulfuryl chloride. Formulation input ratio is tightly goverened: the exchange step uses 2-bromo-5-methylthiazole, spray-dried potassium fluoride (KF, ≤500 ppm H₂O), and cuprous iodide in a molar charge of 1 : 2.2 : 0.05 within anhydrous dimethylformamide. Process deviation beyond 1 : 2.0 fluoride leads to incomplete conversion; above 2.5, the generation of potassium bromide fines accelerates abrasion in centrifugal pumps. Regulatory compliance under EPA 40 CFR 180 and EU Regulation 396/2005 mandates a total brominated by-product limit below 0.1% w/w in the technical concentrate. Downstream, the 2-chloro-5-chloromethylthiazole is condensed with 3-methyl-4-nitroimino-1,3,5-oxadiazinane in acetonitrile at 45–50 °C to yield the active ingredient. On a 5000 L glass-lined reactor train, the narrow reaction exotherm—ΔT failure mode observed when jacket cooling fails to respond within 90 seconds—produces a dimeric impurity spike above 2%, irreversibly contaminating the batch. Terminal product types are 25% WG (water-dispersible granules) and 350 g/L FS (flowable concentrate for seed treatment).

    ParameterRangeObserved Yield Loss
    Reaction temperature (halogen exchange)130–138 °COutside window: 12–18% drop
    Moisture content KF charge≤500 ppmAt 1200 ppm: 35% KF consumed by hydrolysis
    CuI particle size (D₅₀)15–25 μmCoarser grades raise induction period by 2 h

    In the production of orally administered cephalosporin prodrugs, 2-bromo-4-methylthiazole-5-acetic acid is converted to a mixed anhydride and condensed with 7-amino-3-(4-methylthiazol-5-yl)methyl-3-cephem-4-carboxylate. The active ester formulation ratio in the acylation vessel—typically a 3000 L stainless-steel reactor with retreated-blade agitator operating at 85 rpm—is 1.2 mol of the thiazole side-chain per 1.0 mol of the β-lactam nucleus. Charge sequencing is irreversible: the pre-cooled (−10 °C) nucleus slurry is dosed into the activated acid solution to prevent exothermic spikes exceeding 2 °C/min, which crosslink the cephem ring generating a Δ³-isomer burden above pharmacopoeial limits. Compliance follows ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients) and FDA 21 CFR Part 211, with residual bromine species controlled by a validated HPLC method (LOD 50 ppm). Production-scale experience documents an impurity RRT 1.34 reaching 0.82% when the median mixing time in the interface region of the half-pipe coil jacket exceeds 12 seconds—a condition alleviated by retrofitting with a tri-shaft baffle array. The crystallized sodium salt intermediate is dried in a 0.1 bar conical screw dryer to ≤0.5% LOD. Terminal products are film-coated tablets of cefditoren pivoxil (200 mg and 400 mg) and granules for oral suspension.

    Palladium-catalyzed cross-coupling of 2-bromothiazole with tri-n-butyl(1-ethoxyvinyl)tin at 0.95:1 molar ratio (bromide limiting to suppress organotin carryover) generates a ketone precursor that, after acid hydrolysis at pH 2.0–2.5 and vacuum fractional distillation, yields 2-acetylthiazole. This substance meets FEMA GRAS 3328 and JECFA 1041 specifications for flavoring preparations, with permitted carryover of inorganic bromide below 30 ppm. The downstream formulation of process flavors adds the ingredient at 0.02–5.0 ppm in the final food matrix, imparting nutty and roasted-meat notes. Equipment used is a 50 L glass-lined still coupled to a 12-inch Vigreux column; the heart cut is collected at 89–91 °C under 12 mmHg. Terminal product types are liquid flavor compounds for savory snacks and retorted soups.

    Donor–Acceptor Copolymer Bandgap Tuning via Thiazole Monomers

    Organic field-effect transistor (OFET) fabrication utilizes the electron-deficient character of 2,5-dibromothiazole to construct alternating copolymers. Polycondensation with 5,5′-bis(trimethylstannyl)-2,2′-bithiophene proceeds via Stille coupling in anhydrous chlorobenzene under N₂ atmosphere at 130 °C for 48 h. The molecular-weight-critical stoichiometric ratio is 1 : 1.000; a deviation of only ±0.25 mol% shifts the number-average molecular weight (Mₙ) from 28 kDa (Ð ≈ 2.1) to below 12 kDa, rendering the film brittle. End-capping is performed with 2-tributylstannylthiophene and 2-bromothiophene sequentially. Manufacturing complies with RoHS 2011/65/EU for residual heavy metals, and tin content is analyzed per IEC 62321-5:2013. Processing hazards include the formation of a palladium black colloidal suspension if the P(o-tolyl)₃:Pd₂(dba)₃ ratio drops below 8 : 1, which shuts down chain extension. The polymer is purified by successive Soxhlet extraction with methanol, acetone, and hexane, then dissolved in chloroform and filtered through a 0.45 μm PTFE membrane. Terminal product forms are spin-coated semiconductor layers in bottom-gate top-contact OFETs with mobilities of 0.15–0.35 cm²/V·s.

    Catalyst SystemMₙ (GPC, vs PS standards)Dispersity Ð
    Pd₂(dba)₃ / P(o-tolyl)₃ (1:8)28–34 kDa2.0–2.3
    Pd(PPh₃)₄ (2 mol%)15–19 kDa2.6–3.1
    Pd(OAc)₂ / SPhos (1:2.5)22–27 kDa2.2–2.5

    When 2-Bromothiazole Replaces 2-Bromobenzothiazole in Asymmetric Cyanine Dye Synthesis

    Flow cytometry and qPCR detection systems employ asymmetric cyanine dyes wherein 2-bromothiazole is condensed with 1-methylquinolinium salts in methanol under basic conditions. The molar feed ratio of 2-bromothiazole to the quinolinium intermediate is 1.05 : 1 in the presence of 1.5 equivalents of triethylamine; the mixture is heated to 65 °C for 3 h to form the monomethine bridge. Substituting the traditional benzothiazole ring with thiazole blue-shifts the absorption maximum from ∼500 nm toward 475 nm, permitting multiplexed optical channels. Quality conformance abides by ISO 13485:2016 as a biochemical reagent, and palladium clearance is monitored via inductively coupled plasma mass spectrometry to <10 ppm. The raw dye is purified on a silica gel 60 Å column with a dichloromethane/methanol (9:1) mobile phase. Terminal product types are lyophilized powders for propidium iodide-alternative dead-cell stains and SYBR Green-complementary nucleic acid gel stains.

    Free Quote

    Competitive Bromo-Thiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    In its most widely specified industrial form, Bromo-Thiazole refers to 2-bromothiazole (CAS 3034-53-5), supplied as the clear, straw‑colored liquid BT‑98 grade. The primary specification, verified by GC area% per ASTM E202-12, sets a minimum purity of ≥ 98.5 % with the isomeric impurity 5‑bromothiazole capped at ≤ 0.4 % and dibrominated congeners below 0.3 %. Physical constants for this lot‑controlled material—boiling point 65–67 °C at 15 mmHg, density 1.680–1.690 g·mL⁻¹ at 25 °C, and refractive index n²⁰D 1.593–1.595—are documented on each certificate of analysis and correspond to the data for the neat liquid as summarized in Beilstein registry records. The compound functions as a building block for C–C and C–heteroatom bond constructions where the thiazole ring imparts a substantially lower π‑electron density than pyridine or bromobenzene analogs, a property that directly dictates catalyst selection and base strength in palladium‑mediated transformations.

    Which Process‑Scale Impurities Define the BT‑98 Grade?

    Experience from bulk distillation campaigns using wiped‑film evaporators with evaporator surface areas of 0.5 m² and jacket temperatures held at 80–85 °C reveals that the critical impurity profile is governed less by the bromination feed ratio and more by the thermal history of the crude during rectification. The principal contaminant, 5‑bromothiazole, arises via a HBr‑catalyzed equilibration that becomes kinetically relevant above 70 °C when the residence time in the hot zone exceeds 120 seconds. Batch‑to‑batch variance observed on a 200 L glass‑lined still operating at 10–12 mbar consistently tracks the fluctuation in cooling water temperature at the cold trap; a rise from –5 °C to +2 °C correlates with a 0.15 % absolute increase in 5‑bromothiazole in the distillate. Consequently, the BT‑98 specification includes an ion chromatography limit for bromide (liberated from thermal dehydrohalogenation) of ≤ 50 ppm and a Karl‑Fischer water content of ≤ 100 ppm, as moisture amplifies glass‑lining corrosion and subsequent iron‑catalyzed dehalogenation in downstream coupling steps.

    Catalyst Matching and Solvent Constraints in Palladium‑Catalyzed Cross‑Coupling of 2‑Bromothiazole

    The oxidative addition of 2‑bromothiazole onto Pd⁰ proceeds at a rate that is 8–12 times faster than that of 2‑chlorothiazole but roughly two orders of magnitude slower than the 2‑iodo analogue when the catalyst is Pd(PPh₃)₄ in THF at 60 °C, as determined by competitive Gas Chromatography–Isotope Ratio Monitoring Mass Spectrometry experiments. This intermediate reactivity window dictates a narrow processing window for Suzuki‑Miyaura couplings: catalyst loadings below 0.05 mol % Pd result in stalled conversion at the bromide stage, while any excursion above 0.5 mol % promotes homocoupling of the boronic acid partner to biaryls that co‑elute with the target thiazole product during silica‑gel chromatography. Production‑scale vessels with an anchor‑type agitator operating at 120 rpm and heat‑transfer coefficients of 150–200 W·m⁻²·K⁻¹ routinely employ Pd₂(dba)₃ (0.1 mol %) and XPhos (0.24 mol %) in a toluene/water biphasic system with 2.0 equivalents of K₃PO₄ as the base. Under these conditions, internal temperature must be controlled to 80 ± 2 °C; excursions beyond 84 °C induce rapid catalyst decomposition to palladium black, visible as a grey‑to‑black ring at the liquid‑vapor interface, and a concomitant drop in conversion from >95 % to <40 % within 15 minutes. The dissolved oxygen threshold during sparging is tightened to ≤ 5 ppm, as thiazole‑derived Pd‑Ar intermediates are prone to reductive elimination of the thiazole‑H species when adventitious oxygen promotes phosphine oxidation. No two‑step sequence illustrates the criticality of bromine‑specific electrophilicity better than the preparation of 2‑aminothiazole libraries via Buchwald‑Hartwig amination. Here, the 2‑bromothiazole substrate delivers full conversion with Pd(dba)₂ / BINAP at 1 mol % and NaOtBu in toluene at 100 °C within 3 hours, whereas 5‑bromothiazole requires 18 hours to reach 78 % conversion under identical conditions. The differential stems from a 0.45 eV lift in the LUMO energy at C‑5, confirmed by density functional calculations at the B3LYP/6‑31+G(d) level, which raises the energy barrier for nucleophilic attack and shifts the rate‑determining step from oxidative addition to deprotonation of the amine‑Pd complex. On a 50 kg scale campaign, replacement of 2‑bromothiazole with the 5‑isomer forced a reactor cycle‑time extension from 8 hours to 33 hours, increased the palladium inventory by 2.5×, and elevated the residual heavy‑metal burden in the crude to 320 ppm versus 45 ppm for the 2‑bromo feed.

    When 2‑Bromothiazole Replaces 2‑Chlorothiazole in Aryl Amination: Rate Acceleration and Impurity Profiles

    Switching the halogen from chlorine to bromine in thiazole‑based C–N bond formation lowers the activation enthalpy by ≈ 20 kJ·mol⁻¹ and permits a reduction of the Xantphos ligand loading from 1.2 mol % to 0.6 mol % while retaining > 90 % conversion. Yet this substitution introduces an exclusion zone for amine bases: while 2‑chlorothiazole systems can operate with N,N‑diisopropylethylamine as the scavenger, 2‑bromothiazole undergoes competitive debromination to thiazole via β‑hydride elimination of the palladium‑amido intermediate when secondary amines are present above 0.5 equivalents. The debrominated side product, thiazole itself, co‑distills with the product in subsequent wiped‑film purification and necessitates a secondary extractive wash with 5 % aqueous citric acid to lower its titer below 0.2 %. Consequently, suppliers of BT‑98 advise against any storage or reaction vessel that previously contacted diisopropylamine without an 8‑hour acid‑rinse cycle at 60 °C. A comparative table of physical and reactivity parameters across the commercially accessible halogenated thiazoles is provided below; the data were collected on a single batch of each analogue with purity ≥ 98 % as confirmed by GC‑FID.
    Comparative Physical and Reactivity Data for Halogenated Thiazoles
    Parameter 2‑Bromothiazole 2‑Chlorothiazole 2‑Iodothiazole 5‑Bromothiazole
    CAS number 3034-53-5 3034-52-4 3034-55-7 4175-77-3
    Molecular weight (g·mol⁻¹) 163.99 119.55 210.99 163.99
    Boiling point (°C / mmHg) 65–67 / 15 71–72 / 50 82–84 / 15 86–88 / 25
    Half‑wave potential E₁/₂ (V vs SCE)⁽¹⁾ −1.87 −2.12 −1.54 −2.03
    Relative rate Suzuki coupling⁽²⁾ with PhB(OH)₂, Pd(PPh₃)₄ 1.00 (ref.) 0.14 6.3 0.05
    Typical purity specification (GC area%) ≥ 98.5 ≥ 98.0 ≥ 97.0 ≥ 97.5
    ⁽¹⁾ Measured in DMF/0.1 M TBAPF₆ at a glassy carbon electrode, scan rate 100 mV·s⁻¹. ⁽²⁾ Rate normalized to 2‑bromothiazole; conditions: 1.0 mmol halide, 1.2 mmol boronic acid, 0.05 mol % Pd(PPh₃)₄, K₂CO₃ (2 equiv), THF‑H₂O 4:1, 60 °C, initial rates.
    Beyond the coupling arena, the unique placement of bromine at the 2‑position of the 1,3‑thiazole scaffold renders it the electrophile of choice for directed ortho‑metalation (DoM) reversal strategies. Where a 2‑chlorothiazole may survive iterative LDA treatment at −78 °C, 2‑bromothiazole undergoes lithium‑bromine exchange with 1.05 equiv of n‑BuLi in THF at −98 °C within 15 seconds, generating the 2‑lithiothiazole species required to trap CO₂ or DMF. The window of thermal stability for this lithiated intermediate is ≤ −85 °C; at −80 °C, ring‑opening to a thioenolate dominates within 3 minutes, as evidenced by the characteristic 255 nm UV absorption peak of the decomposition product. Facilities performing kilogram‑scale lithiation therefore equip their 100 L Hastelloy reactors with a liquid‑nitrogen jacketed feed line and maintain a constant internal temperature of −95 ± 2 °C, confirmed by a redundant duplex platinum resistance thermometer assembly. In the synthesis of the agrochemical fungicide fenoxanil, 2‑bromothiazole participates in a Negishi coupling with an arylzinc reagent derived from 2,6‑dichlorobenzotrifluoride. The throughput demand of 1.2 tonnes·yr⁻¹ for the thiazole‑containing intermediate forces a profound sensitivity to zincate stoichiometry. Metering the organozinc solution at 0.98 equiv relative to the bromide ensures that residual 2‑bromothiazole remains below 1.5 % post‑reaction, avoiding a costly recrystallization to remove unreacted halide which otherwise crystals with the product in a 2:3 solid‑solution habit. The limit of detection for free bromide, set by ion‑selective electrode at 0.8 ppm, serves as the in‑process control to gate the feed rate of the Grignard‑derived zincate. Any batch exhibiting a bromide concentration above 150 ppm after quench is diverted to a regenerative‑resin polishing step because residual ionic bromide catalyzes the acid‑mediated ring cleavage of the fenoxanil precursor during the subsequent acidic cyclization conducted in glacial acetic acid at 115 °C. Storage stability under recommended conditions (2–8 °C, under dry nitrogen with a headspace relative humidity <5 %) has been validated for 24 months through an ICH‑compliant protocol with quarterly testing per the BT‑98 monograph. Photodegradation is the dominant failure mode: exposure to ambient fluorescent lighting (400–700 nm, 12,000 lux) for 72 hours results in a 2.1 % absolute increase in the 5‑bromothiazole isomer and the appearance of an unknown at RRT 1.23. Bulk containers larger than 200 L are fabricated from HDPE with an integrated UV‑absorbent liner rated to 0.05 % transmittance at 340 nm. Amine‑based stabilizers are specifically prohibited because even 100 ppm of triethylamine triples the rate of hydrobromic acid elimination to form thiazole, measured by headspace GC‑MS.